HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PTN
Palatin Technologies, Inc.
There isn't enough reported data to score PTN yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PTN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
PTN's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PTN PE Valuation
PTN has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PTN Forward outlook
There aren't enough analyst estimates for PTN to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
PTN Earnings Per Share
PTN and HIMS do not have enough comparable growth data to identify a winner.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over PTN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over PTN on profitability, with a higher operating margin.
PTN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2024 | $350K | -80% |
| Q4 2023 | $2M | +98% |
| Q2 2023 | $1.8M | +129% |
| Q1 2023 | $1.2M | +453% |
| Q4 2022 | $1M | +311% |
| Q2 2022 | $770.7K | +340% |
| Q1 2022 | $216.1K | +144% |
PTN's revenue is growing: $300,770 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1469% | N/A |
| Q1 2026 | -40% | N/A |
| Q4 2025 | -6316% | N/A |
| Q3 2025 | 53% | N/A |
| Q2 2024 | -2383% | -1770 points |
| Q4 2023 | 58% | +602 points |
| Q3 2023 | -290% | N/A |
| Q2 2023 | -614% | +1086 points |
PTN's operating margin was −1469% last quarter, up 914 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
PTN has the stronger cash trend. Its trailing FCF is down 23% versus its history, compared with HIMS at down 84%.
PTN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.7M | +$1.4M |
| Q1 2026 | -$4.5M | +$898.7K |
| Q3 2025 | -$1.6M | +$5.4M |
| Q2 2025 | -$4.1M | +$2.4M |
| Q1 2025 | -$5.4M | +$3.3M |
| Q4 2023 | -$10.5M | +$6.9M |
| Q4 2022 | -$17.4M | -$11M |
| Q3 2022 | -$24.7K | +$6.5M |
PTN has burned cash in almost every quarter: −$13M over the past year, against −$27M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over PTN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PTN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +54% | +1.4M shares |
| 1 year | +848% | +3.5M shares |
| 3 years | +1789% | +3.7M shares |
| 5 years | +1978% | +3.7M shares |
| Available history | +2262% | +3.7M shares |
PTN has 4M diluted shares, up 848% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PTN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | -2.5x | Net Cash |
| Q4 2019 | -2.5x | Net Cash |
| Q3 2019 | -2.6x | Net Cash |
| Q2 2019 | -1.2x | Net Cash |
PTN has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PTN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.7 | Neutral |
| Stochastic | 15.1 | Oversold |
PTN's weekly RSI is 38 (neutral) and its Stochastic is 15 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PTN PE vs Healthcare Sector
PTN has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PTN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.12 | 7.7% below |
| 20 week MA | $8.79 | 25% below |
| 50 week MA | $14.4 | 54% below |
| 100 week MA | $17.7 | 63% below |
| 200 week MA | $63.0 | 90% below |
PTN is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over PTN on returns for 2026, with the stronger performance.
PTN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,000.0 | $837.5 | -16% |
| 2021 | $837.5 | $650.0 | -22% |
| 2022 | $650.0 | $118.0 | -82% |
| 2023 | $118.0 | $199.0 | +69% |
| 2024 | $199.0 | $55.5 | -72% |
| 2025 | $55.5 | $14.6 | -74% |
| 2026 YTD | $14.6 | $6.57 | -55% |
PTN has finished lower in five of the last six years. It's down 55% so far in 2026.